Pharmacy intervention on antimicrobial management of critically ill patients;Intervención farmacéutica en el manejo antimicrobiano de pacientes críticamente enfermos

Pharmacy Practice

Volumn 9, Issue 2, 2011, Pages 106-109

  Ijo, Immanuel ^a   Feyerharm, Jeffrey ^a  

^a Asante Health System   (United States)

Author keywords

Anti infective agents; Cost benefit analysis; Hospital; Intensive care; Pharmacy service; United states

Indexed keywords

ANTIMICROBIAL THERAPY; ARTICLE; CRITICALLY ILL PATIENT; DRUG COST; DRUG INFORMATION; HUMAN; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; MEDICATION THERAPY MANAGEMENT; MORTALITY; PHARMACIST; PHARMACY; PHYSICIAN; TREATMENT OUTCOME;

EID: 79959390445     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552011000200008     Document Type: Article

References (12)

1. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159-177.
2. Ansari F, Gray K, Nathwani D, Phillips G, Ogston S, Ramsay C, Davey P. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemo. 2003;52(5):842-848.
3. Roberts RR, Hota B, Ahmad I, Scott RD 2nd, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antimicrobial stewardship. Clin Infect Dis. 2009;49(8):1175-1184.
4. MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care o critically ill patients with infections. Crit Care Med. 2008;36(12):3184-3189.
5. Arabi Y, Venkatesh S, Haddad S, Al Shimemeri A, Al Malik S. Prospective study of prolonged stay in the intensive care unit: predictors and impact of resource utlization. Int J Qual Health Care. 2002;14(5):403-410.
6. Paterson DL. Role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis. 2006;42(Suppl 2):S90-95.
7. Kollef MH. Bench-to-bedside review: Antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit. Crit Care. 2005;9(5):459-464.
8. Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis. 2001;33(3):289-295.
9. Deurenberg RH, Vink C, Kalenic S, Friedrich AW, Bruggeman CA, Stobberingh EE. Molecular evolution of methicillinresistant Staphylococcus aureus. Clin Microbiol Infect. 2007;13(3):222-235.
10. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK; National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29(11):996-1011.
11. National Health Statistics Report. US Department of Health and Human Services. National hospital ambulatory medical care survey: 2006 emergency department summary. 2008;7:10.
12. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis. 2009;15(2):343-344.